| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 3, 1147-1155, Copyright © 1992 by American Society of Nephrology
REGULAR ARTICLES |
CB Nelson, FK Port, RA Wolfe and KE Guire
Michigan Kidney Registry, Ann Arbor 48103.
To evaluate the mortality of continuous ambulatory peritoneal dialysis (CAPD) patients relative to hemodialysis (HD) patients, all Michigan residents 20 to 59 yr of age who initiated therapy for ESRD during the 1980s (N = 4,288) were studied. The study population was stratified by primary renal diagnosis (glomerulonephritis, hypertension, diabetes, other), and analyses were conducted within each group by Cox proportional hazards methods controlling for age, race, sex, and year in which chronic dialysis was initiated. Intent-to-treat (ITT) and treatment history (RxHx) censoring criteria were used. For patients with hypertension or other reported causes of ESRD, there was no significant difference in CAPD and HD patient mortality (relative risk (RR) = 0.99 and 1.05, respectively). In the ITT analysis, both glomerulonephritic (RR = 0.73; P = 0.10) and diabetic patients using CAPD experienced mortality rates lower than their HD counterparts. Among diabetics, this difference ranged from a RR of 0.40 to 0.70, being lowest for younger diabetics and statistically significant (P < or = 0.05) for ages 20 to 52 yr. Evaluation of mortality trends showed a significant (P < 0.01) decrease in diabetic CAPD mortality rates during the decade, whereas diabetic HD mortality rates increased (P = 0.06). Among diabetics, men had higher mortality rates than women (ITT-- RxHx; RR = 1.22 to 1.27; P < 0.001) and white patients had higher mortality rates than black patients (ITT--RxHx, RR = 1.34 to 1.44; P < 0.001). Differences in mortality by sex and race were not found among nondiabetics, but mortality did increase significantly with age in all groups.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
J. K. Inrig, J. L. Sun, Q. Yang, L. P. Briley, and L. A. Szczech Mortality by Dialysis Modality among Patients Who Have End-Stage Renal Disease and Are Awaiting Renal Transplantation Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 774 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, B. Hemmelgarn, B. Manns, S. Davison, C. Bohm, S. Gourishankar, G. Pylypchuk, K. Yeates, and J. S. Gill Use and Outcomes of Peritoneal Dialysis among Aboriginal People in Canada J. Am. Soc. Nephrol., February 1, 2005; 16(2): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2 J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2851 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Winkelmayer, R. J. Glynn, M. A. Mittleman, R. Levin, J. S. Pliskin, and J. Avorn Comparing Mortality of Elderly Patients on Hemodialysis versus Peritoneal Dialysis: A Propensity Score Approach J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2353 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Heaf, H. Lokkegaard, and M. Madsen Initial survival advantage of peritoneal dialysis relative to haemodialysis Nephrol. Dial. Transplant., January 1, 2002; 17(1): 112 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. VAN BIESEN, R. C. VANHOLDER, N. VEYS, A. DHONDT, and N. H. LAMEIRE An Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients J. Am. Soc. Nephrol., January 1, 2000; 11(1): 116 - 125. [Abstract] [Full Text] |
||||
![]() |
D. E. SCHAUBEL and S. S. A. FENTON Trends in Mortality on Peritoneal Dialysis: Canada,1981-1997 J. Am. Soc. Nephrol., January 1, 2000; 11(1): 126 - 133. [Abstract] [Full Text] |
||||
![]() |
E. F. VONESH and J. MORAN Mortality in End-Stage Renal Disease: A Reassessment of Differencesbetween Patients Treated with Hemodialysis and Peritoneal Dialysis J. Am. Soc. Nephrol., February 1, 1999; 10(2): 354 - 365. [Abstract] [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673